Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donglin Yan

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
JCO Precision Oncology|September 11, 2024
Clinical Utility of Molecular Tumor Board Review for Identification of Possible Germline Pathogenic Variants on Tumor Next-Generation Sequencing ReportsTaylor A Rives, James Collard, Ning Li, et al.
JCO Precision Oncology|January 15, 2026
Assessing the Value of Sequential Next-Generation Sequencing and Multiple Molecular Tumor Board Reviews for Patients With Solid-Tumor MalignanciesAllison L Swiecki-Sikora, Lydia Williams, Ning Li, et al.
The International Journal of Biochemistry & Cell Biology|August 23, 2017
Inhibition of PARP1 activity enhances chemotherapeutic efficiency in cisplatin-resistant gastric cancer cellsQiang Wang, Jianping Xiong, Danping Qiu, et al.
Cancers|June 28, 2023
Implementation of Nurse Navigation Improves Rate of Molecular Tumor Testing for Ovarian Cancer in a Gynecologic Oncology PracticeTaylor A Rives, Heather Pavlik, Ning Li, et al.
Cancers|May 5, 2021
Evaluation of Glutaminase Expression in Prostate Adenocarcinoma and Correlation with Clinicopathologic ParametersZin W Myint, Ramon C Sun, Patrick J Hensley, et al.
Frontiers in Oncology|January 2, 2023
Nanopore sequencing of clonal IGH rearrangements in cell-free DNA as a biomarker for acute lymphoblastic leukemiaShilpa Sampathi, Yelena Chernyavskaya, Meghan G Haney, et al.
Cancer Nanotechnology|January 12, 2026
M1 Macrophage-Engineered Vesicles Have Anti-Cancer Activity in Ovarian CancerConnie D Cao, J Robert McCorkle, Derek B Allison, et al.
Cancers|February 27, 2026
A Phase 1 Dose Escalation of Lapatinib and Paclitaxel in Recurrent Ovarian CancerConnie D Cao, Joseph Robert McCorkle, Donglin Yan, et al.
Cancers|May 13, 2023
A Phase I Dose Escalation and Expansion Study of Epidiolex (Cannabidiol) in Patients with Biochemically Recurrent Prostate CancerZin W Myint, William H St Clair, Stephen E Strup, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
JCO Precision Oncology|September 11, 2024
Clinical Utility of Molecular Tumor Board Review for Identification of Possible Germline Pathogenic Variants on Tumor Next-Generation Sequencing ReportsTaylor A Rives, James Collard, Ning Li, et al.
JCO Precision Oncology|January 15, 2026
Assessing the Value of Sequential Next-Generation Sequencing and Multiple Molecular Tumor Board Reviews for Patients With Solid-Tumor MalignanciesAllison L Swiecki-Sikora, Lydia Williams, Ning Li, et al.
The International Journal of Biochemistry & Cell Biology|August 23, 2017
Inhibition of PARP1 activity enhances chemotherapeutic efficiency in cisplatin-resistant gastric cancer cellsQiang Wang, Jianping Xiong, Danping Qiu, et al.
Cancers|June 28, 2023
Implementation of Nurse Navigation Improves Rate of Molecular Tumor Testing for Ovarian Cancer in a Gynecologic Oncology PracticeTaylor A Rives, Heather Pavlik, Ning Li, et al.
Cancers|May 5, 2021
Evaluation of Glutaminase Expression in Prostate Adenocarcinoma and Correlation with Clinicopathologic ParametersZin W Myint, Ramon C Sun, Patrick J Hensley, et al.
Frontiers in Oncology|January 2, 2023
Nanopore sequencing of clonal IGH rearrangements in cell-free DNA as a biomarker for acute lymphoblastic leukemiaShilpa Sampathi, Yelena Chernyavskaya, Meghan G Haney, et al.
Cancer Nanotechnology|January 12, 2026
M1 Macrophage-Engineered Vesicles Have Anti-Cancer Activity in Ovarian CancerConnie D Cao, J Robert McCorkle, Derek B Allison, et al.
Cancers|February 27, 2026
A Phase 1 Dose Escalation of Lapatinib and Paclitaxel in Recurrent Ovarian CancerConnie D Cao, Joseph Robert McCorkle, Donglin Yan, et al.
Cancers|May 13, 2023
A Phase I Dose Escalation and Expansion Study of Epidiolex (Cannabidiol) in Patients with Biochemically Recurrent Prostate CancerZin W Myint, William H St Clair, Stephen E Strup, et al.
Pageof 3